Pending EO 12866 Regulatory Review

RIN: 1117-ZA11	Received Date: 10/14/2026
Title: Schedules of Controlled Substances: Placement of Centanafadine in Schedule III
Agency/Subagency: DOJ / DEA	Stage: Interim Final Rule
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No